SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001062822-14-000066
Filing Date
2014-12-23
Accepted
2014-12-23 14:36:40
Documents
8
Period of Report
2014-12-23

Document Format Files

Seq Description Document Type Size
1 10-Q/A form10-qa.htm 10-Q/A 47472
2 LICENSE AND COLLABORATION AGREEMENT exh101licenseandcollaborat.htm EX-10.1 746560
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER exh311certificationofprinc.htm EX-31.1 12536
4 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER exh312certificationofprinc.htm EX-31.2 11929
5 CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICERS exh321certificationofprinc.htm EX-32.1 8006
6 image0.jpg GRAPHIC 5669
7 image1.jpg GRAPHIC 7308
8 image2.jpg GRAPHIC 5587
  Complete submission text file 0001062822-14-000066.txt   853641
Mailing Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381
Business Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

IRS No.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-30111 | Film No.: 141306283
SIC: 2834 Pharmaceutical Preparations